(object) array(
'id' => '3898055',
'url' => 'FR/fixed_interval_₁',
'image' => '',
'title' => 'Intervalle fixe',
'tags' =>
array (
0 => 'Intervalle fixe',
1 => 'Pharmaceutical',
2 => 'Pharmaceutical intermediates',
3 => '',
),
'term' => 'Intervalle fixe',
'source_id' => 3744254,
'type' => 'term',
'namespace' => 1244,
'nstext' => 'FR',
'industry' =>
array (
0 => 'Pharmaceutical',
),
'category' =>
array (
0 => 'Pharmaceutical intermediates',
),
'lastedit' => '20150722105907',
'part_of_speech' => 'noun',
'creation_user' => 'LinguaDiligence',
'special_term' => '',
'definition' => 'Un programme dans lequel une personne est renforcée par la première réponse après qu\'une période de temps fixe soit passée depuis le renforcement précédent. Ce programme induit généralement une pause après un renforçateur puis une augmentation progressive du rythme d\'émission des réponses jusqu\'à un niveau élevé au moment où le prochain renforçateur est reçu.',
'usage_comment' => '',
'glossary' => '',
'width' => 0,
'height' => 0,
'_version_' => 1507393851744059392,
'nstext_full' => 'French (FR)',
's_attr' =>
(object) array(
'Definition' => 'A schedule in which a person is reinforced for the first response after a fixed period of time has passed since the previous reinforcement. This schedule usually causes people to pause after a reinforcer and then to gradually increase their response rate until they are working at a high rate at the moment they receive the next reinforcer.',
'Domain' => 'Documentation',
'Industry' => 'Pharmaceutical',
'Part of Speech' => 'noun',
'Product Category' => 'Pharmaceutical intermediates',
'Usage Status' => 'New',
'Creation User' => 'lovinbnsingle',
'Creation Date' => '2012/9/5',
'Glossary' => 'MODULE_3_twgid1346807673617222',
'Term' => 'fixed interval',
'Source Lang' => '1180',
),
's_namespace_text' => 'EN',
's_namespace_text_full' => 'English (EN)',
's_title' => 'fixed_interval_₁',
)
fixed interval
A schedule in which a person is reinforced for the first response after a fixed period of time has passed since the previous reinforcement. This schedule usually causes people to pause after a reinforcer and then to gradually increase their response rate ...
Intervalle fixe
Un programme dans lequel une personne est renforcée par la première réponse après qu'une période de temps fixe soit passée depuis le renforcement précédent. Ce programme induit généralement une pause après un renforçateur puis une augmentation progressive du ...
Pharmaceutical; Pharmaceutical intermediates
(object) array(
'id' => '3897820',
'url' => 'FR/variable-interval_₁',
'image' => '',
'title' => 'Intervalle variable',
'tags' =>
array (
0 => 'Intervalle variable',
1 => 'Pharmaceutical',
2 => 'Pharmaceutical intermediates',
3 => '',
),
'term' => 'Intervalle variable',
'source_id' => 3744241,
'type' => 'term',
'namespace' => 1244,
'nstext' => 'FR',
'industry' =>
array (
0 => 'Pharmaceutical',
),
'category' =>
array (
0 => 'Pharmaceutical intermediates',
),
'lastedit' => '20150722105901',
'part_of_speech' => 'noun',
'creation_user' => 'LinguaDiligence',
'special_term' => '',
'definition' => 'Un renforçateur dépend de la première réponse après un intervalle de temps variable depuis la dernière opportunité pour un renforcement.',
'usage_comment' => '',
'glossary' => '',
'width' => 0,
'height' => 0,
'_version_' => 1507393851727282176,
'nstext_full' => 'French (FR)',
's_attr' =>
(object) array(
'Definition' => 'A reinforcer is contingent on the first response after a variable interval of time since the last opportunity for reinforcement.',
'Domain' => 'Documentation',
'Industry' => 'Pharmaceutical',
'Part of Speech' => 'noun',
'Product Category' => 'Pharmaceutical intermediates',
'Usage Status' => 'New',
'Creation User' => 'lovinbnsingle',
'Creation Date' => '2012/9/5',
'Glossary' => 'MODULE_3_twgid1346807673617222',
'Term' => 'variable-interval',
'Source Lang' => '1180',
),
's_namespace_text' => 'EN',
's_namespace_text_full' => 'English (EN)',
's_title' => 'variable-interval_₁',
)
variable-interval
A reinforcer is contingent on the first response after a variable interval of time since the last opportunity for reinforcement.
Intervalle variable
Un renforçateur dépend de la première réponse après un intervalle de temps variable depuis la dernière opportunité pour un renforcement.
Pharmaceutical; Pharmaceutical intermediates
(object) array(
'id' => '2315639',
'url' => 'FR/spirulina_₁',
'image' => 'espirulina-3.jpg',
'title' => 'Spiruline',
'tags' =>
array (
0 => 'Spiruline',
1 => 'Pharmaceutical',
2 => 'Healthcare supplement',
3 => '',
),
'term' => 'Spiruline',
'source_id' => 1658962,
'type' => 'term',
'namespace' => 1244,
'nstext' => 'FR',
'industry' =>
array (
0 => 'Pharmaceutical',
),
'category' =>
array (
0 => 'Healthcare supplement',
),
'lastedit' => '20150721112809',
'part_of_speech' => 'noun',
'creation_user' => 'LinguaDiligence',
'special_term' => '',
'definition' => 'La spiruline est une bactérie bleu-vert du groupe des cyanobactéries ayant une forte valeur nutritionnelle : elle contient des protéines et de la vitamine B12. Les compléments alimentaires sont composés de deux espèces de spiruline : Arthrospira platensis et Arthrospira maxima. Elle est devenue populaire en tant que complément alimentaire à la fin du XXe siècle.',
'usage_comment' => '',
'glossary' => '',
'width' => 250,
'height' => 280,
'_version_' => 1507305079939530752,
'nstext_full' => 'French (FR)',
's_attr' =>
(object) array(
'Term' => 'spirulina',
'Definition' => 'Spirulina is a green-blue bacterium of the Cyanobacteria group of a high nutritional value: it contains proteins and B12 vitamin. The nutritional supplements are made of two species of spirulina: Arthrospira platensis and Arthrospira maxima. It became popular as a nutritional supplement at the end of the XX century.',
'Part of Speech' => 'noun',
'Usage Status' => 'New',
'Industry' => 'Pharmaceutical',
'Product Category' => 'Healthcare supplement',
'Creation User' => 'esb',
'Creation Date' => '2011/10/6',
'Sample Image' => 'espirulina-3.jpg',
'Source Lang' => '1180',
),
's_namespace_text' => 'EN',
's_namespace_text_full' => 'English (EN)',
's_title' => 'spirulina_₁',
)
spirulina
Spirulina is a green-blue bacterium of the Cyanobacteria group of a high nutritional value: it contains proteins and B12 vitamin. The nutritional supplements are made of two species of spirulina: Arthrospira platensis and Arthrospira maxima. It became popular ...
Spiruline
La spiruline est une bactérie bleu-vert du groupe des cyanobactéries ayant une forte valeur nutritionnelle : elle contient des protéines et de la vitamine B12. Les compléments alimentaires sont composés de deux espèces de spiruline : Arthrospira platensis et ...
Pharmaceutical; Healthcare supplement
(object) array(
'id' => '5178801',
'url' => 'FR/treatment-naive_₁',
'image' => '',
'title' => 'Patient naïf de traitement',
'tags' =>
array (
0 => 'Patient naïf de traitement',
1 => 'Pharmaceutical',
2 => 'Drugs',
3 => 'Tylenol',
4 => '',
),
'term' => 'Patient naïf de traitement',
'source_id' => 3284753,
'type' => 'term',
'namespace' => 1244,
'nstext' => 'FR',
'industry' =>
array (
0 => 'Pharmaceutical',
),
'category' =>
array (
0 => 'Drugs',
),
'product' =>
array (
0 => 'Tylenol',
),
'lastedit' => '20150721112814',
'part_of_speech' => 'adjective',
'creation_user' => 'LinguaDiligence',
'special_term' => '',
'definition' => '\'Patient naïf de traitement\' ou \'Patient naïf de médicaments\' se réfère à quelqu\'un n\'ayant encore jamais pris de traitement contre le VIH. Quelqu\'un qui prend déjà des médicaments est appelé \'patient déjà sous traitement\'.',
'usage_comment' => '',
'glossary' => '',
'width' => 0,
'height' => 0,
'_version_' => 1507305079942676480,
'nstext_full' => 'French (FR)',
's_attr' =>
(object) array(
'Term' => 'treatment-naive',
'Definition' => '‘Treatment-naive’ or ‘drug naive’ refers to someone who has never used HIV drugs. Someone who has used drugs before is called ‘treatment-experienced’.',
'Part of Speech' => 'adjective',
'Usage Status' => 'New',
'Industry' => 'Pharmaceutical',
'Product Category' => 'Drugs',
'Product' => 'Tylenol',
'Creation User' => 'Chiara conte',
'Creation Date' => '2012/6/29',
'Source Lang' => '1180',
),
's_namespace_text' => 'EN',
's_namespace_text_full' => 'English (EN)',
's_title' => 'treatment-naive_₁',
)
treatment-naive
‘Treatment-naive’ or ‘drug naive’ refers to someone who has never used HIV drugs. Someone who has used drugs before is called ‘treatment-experienced’.
Patient naïf de traitement
'Patient naïf de traitement' ou 'Patient naïf de médicaments' se réfère à quelqu'un n'ayant encore jamais pris de traitement contre le VIH. Quelqu'un qui prend déjà des médicaments est appelé 'patient déjà sous traitement'.
(object) array(
'id' => '7745836',
'url' => 'FR/informed_consent_₇',
'image' => '',
'title' => 'Consentement éclairé',
'tags' =>
array (
0 => 'Consentement éclairé',
1 => 'Pharmaceutical',
2 => 'Clinical trials',
3 => '',
),
'term' => 'Consentement éclairé',
'source_id' => 1259720,
'type' => 'term',
'namespace' => 1244,
'nstext' => 'FR',
'industry' =>
array (
0 => 'Pharmaceutical',
),
'category' =>
array (
0 => 'Clinical trials',
),
'lastedit' => '20150721084111',
'part_of_speech' => 'noun',
'creation_user' => 'LinguaDiligence',
'special_term' => '',
'definition' => 'Un processus afin de s\'assurer que les patients volontaires comprennent tous les risques associés à la participation à un essai clinique tels que les effets indésirables et choisissent de participer sans coercition ni pression de quiconque. Le chercheur principal ou de ses associés sont tenus d\'expliquer l\'étude attentivement et répondre à toutes les questions d\'un participant avant l\'essai clinique.',
'usage_comment' => '',
'glossary' => '',
'width' => 0,
'height' => 0,
'_version_' => 1507294573052821505,
'nstext_full' => 'French (FR)',
's_attr' =>
(object) array(
'Term' => 'informed consent',
'Definition' => 'A process to ensure that patient volunteers understand all the risks associated participating in a clinical trial such as adverse side effects and are choosing to participate without coercion or pressure from anyone. The principal investigator or his or her associates are required to explain the study carefully and answer all questions of a participant before the clinical trial.',
'Part of Speech' => 'noun',
'Usage Status' => 'New',
'Industry' => 'Pharmaceutical',
'Product Category' => 'Clinical trials',
'Creation User' => 'John Martin',
'Creation Date' => '2011/5/16',
'Source Lang' => '1180',
),
's_namespace_text' => 'EN',
's_namespace_text_full' => 'English (EN)',
's_title' => 'informed_consent_₇',
)
informed consent
A process to ensure that patient volunteers understand all the risks associated participating in a clinical trial such as adverse side effects and are choosing to participate without coercion or pressure from anyone. The principal investigator or his or her ...
Consentement éclairé
Un processus afin de s'assurer que les patients volontaires comprennent tous les risques associés à la participation à un essai clinique tels que les effets indésirables et choisissent de participer sans coercition ni pression de quiconque. Le chercheur ...
Pharmaceutical; Clinical trials
(object) array(
'id' => '7745593',
'url' => 'FR/study_coordinator',
'image' => '',
'title' => 'Coordinateur de l\'étude clinique',
'tags' =>
array (
0 => 'Coordinateur de l\'étude clinique',
1 => 'Pharmaceutical',
2 => 'Clinical trials',
3 => '',
),
'term' => 'Coordinateur de l\'étude clinique',
'source_id' => 1259718,
'type' => 'term',
'namespace' => 1244,
'nstext' => 'FR',
'industry' =>
array (
0 => 'Pharmaceutical',
),
'category' =>
array (
0 => 'Clinical trials',
),
'lastedit' => '20150721084111',
'part_of_speech' => 'noun',
'creation_user' => 'LinguaDiligence',
'special_term' => '',
'definition' => 'Un membre du personnel qui, travaillant pour l\'investigateur principal, contacte les patients par rapport à l\'inscription à l\'étude, planifie les rendez-vous, maintient les registres nécessaires et gère le fonctionnement quotidien de l\'étude.',
'usage_comment' => '',
'glossary' => '',
'width' => 0,
'height' => 0,
'_version_' => 1507294573052821504,
'nstext_full' => 'French (FR)',
's_attr' =>
(object) array(
'Term' => 'study coordinator',
'Definition' => 'A staff person who works for the principal investigator to contact patients about enrolling in the study, schedule appointments, maintain required records and manage the day-to-day operation of the study.',
'Part of Speech' => 'noun',
'Usage Status' => 'New',
'Industry' => 'Pharmaceutical',
'Product Category' => 'Clinical trials',
'Creation User' => 'John Martin',
'Creation Date' => '2011/5/16',
'Source Lang' => '1180',
),
's_namespace_text' => 'EN',
's_namespace_text_full' => 'English (EN)',
's_title' => 'study_coordinator',
)
study coordinator
A staff person who works for the principal investigator to contact patients about enrolling in the study, schedule appointments, maintain required records and manage the day-to-day operation of the study.
Coordinateur de l'étude clinique
Un membre du personnel qui, travaillant pour l'investigateur principal, contacte les patients par rapport à l'inscription à l'étude, planifie les rendez-vous, maintient les registres nécessaires et gère le fonctionnement quotidien de l'étude.
Pharmaceutical; Clinical trials
(object) array(
'id' => '6229990',
'url' => 'FR/other_adverse_event',
'image' => '',
'title' => 'Autre événement indésirable',
'tags' =>
array (
0 => 'Autre événement indésirable',
1 => 'Medical devices',
2 => 'Pharmaceutical',
3 => 'Clinical trials',
4 => 'National Library of Medicine',
5 => '',
),
'term' => 'Autre événement indésirable',
'source_id' => 4011599,
'type' => 'term',
'namespace' => 1244,
'nstext' => 'FR',
'industry' =>
array (
0 => 'Medical devices',
1 => 'Pharmaceutical',
),
'category' =>
array (
0 => 'Clinical trials',
),
'company' =>
array (
0 => 'National Library of Medicine',
),
'lastedit' => '20150722110608',
'part_of_speech' => 'noun',
'creation_user' => 'LinguaDiligence',
'special_term' => '',
'definition' => 'Un événement indésirable qui n\'est pas un événement indésirable grave.',
'usage_comment' => '',
'glossary' => '',
'width' => 0,
'height' => 0,
'_version_' => 1507394292252934144,
'nstext_full' => 'French (FR)',
's_attr' =>
(object) array(
'Company' => 'National Library of Medicine',
'Definition' => 'An adverse event that is not a serious adverse event.',
'Industry' => 'Medical devices; Pharmaceutical',
'Part of Speech' => 'noun',
'Product Category' => 'Clinical trials',
'Creation User' => 'elighy',
'Creation Date' => '2012/10/13',
'Term' => 'other adverse event',
'Source Lang' => '1180',
),
's_namespace_text' => 'EN',
's_namespace_text_full' => 'English (EN)',
's_title' => 'other_adverse_event',
)
other adverse event
An adverse event that is not a serious adverse event.
Autre événement indésirable
Un événement indésirable qui n'est pas un événement indésirable grave.
Medical devices; Clinical trials
(object) array(
'id' => '6229091',
'url' => 'FR/study_design',
'image' => '',
'title' => 'Plan d\'étude',
'tags' =>
array (
0 => 'Plan d\'étude',
1 => 'Medical devices',
2 => 'Pharmaceutical',
3 => 'Clinical trials',
4 => 'National Library of Medicine',
5 => '',
),
'term' => 'Plan d\'étude',
'source_id' => 4011443,
'type' => 'term',
'namespace' => 1244,
'nstext' => 'FR',
'industry' =>
array (
0 => 'Medical devices',
1 => 'Pharmaceutical',
),
'category' =>
array (
0 => 'Clinical trials',
),
'company' =>
array (
0 => 'National Library of Medicine',
),
'lastedit' => '20150727104709',
'part_of_speech' => 'noun',
'creation_user' => 'LinguaDiligence',
'special_term' => '',
'definition' => 'Les méthodes d\'investigation utilisées dans l\'étude clinique. Pour les études interventionnelles, celles-ci incluent un objectif principal, un modèle d\'intervention, en insu ou en aveugle, et une affectation.',
'usage_comment' => '',
'glossary' => '',
'width' => 0,
'height' => 0,
'_version_' => 1507846081754431489,
'nstext_full' => 'French (FR)',
's_attr' =>
(object) array(
'Company' => 'National Library of Medicine',
'Definition' => 'The investigative methods used in the clinical study. For interventional studies, these include primary purpose, intervention model , masking or blinding, and allocation.',
'Industry' => 'Medical devices; Pharmaceutical',
'Part of Speech' => 'noun',
'Product Category' => 'Clinical trials',
'Creation User' => 'elighy',
'Creation Date' => '2012/10/13',
'Term' => 'study design',
'Source Lang' => '1180',
),
's_namespace_text' => 'EN',
's_namespace_text_full' => 'English (EN)',
's_title' => 'study_design',
)
study design
The investigative methods used in the clinical study. For interventional studies, these include primary purpose, intervention model , masking or blinding, and allocation.
Plan d'étude
Les méthodes d'investigation utilisées dans l'étude clinique. Pour les études interventionnelles, celles-ci incluent un objectif principal, un modèle d'intervention, en insu ou en aveugle, et une affectation.
Medical devices; Clinical trials
(object) array(
'id' => '6230217',
'url' => 'FR/investigational_new_drug_₁',
'image' => '',
'title' => 'Nouveau médicament expérimental',
'tags' =>
array (
0 => 'Nouveau médicament expérimental',
1 => 'Medical devices',
2 => 'Pharmaceutical',
3 => 'Clinical trials',
4 => 'National Library of Medicine',
5 => '',
),
'term' => 'Nouveau médicament expérimental',
'source_id' => 4011789,
'type' => 'term',
'namespace' => 1244,
'nstext' => 'FR',
'industry' =>
array (
0 => 'Medical devices',
1 => 'Pharmaceutical',
),
'category' =>
array (
0 => 'Clinical trials',
),
'company' =>
array (
0 => 'National Library of Medicine',
),
'lastedit' => '20150727104715',
'part_of_speech' => 'noun',
'creation_user' => 'LinguaDiligence',
'special_term' => '',
'definition' => 'Un médicament ou produit biologique qui est utilisé dans un essai clinique, mais pas approuvé par la FDA (soit le médicament n\'est pas disponible pour la prescription par un médecin, soit il est disponible, mais pas approuvé par la FDA pour l\'utilisation en cours d\'étude).',
'usage_comment' => '',
'glossary' => '',
'width' => 0,
'height' => 0,
'_version_' => 1507846081755480066,
'nstext_full' => 'French (FR)',
's_attr' =>
(object) array(
'Company' => 'National Library of Medicine',
'Definition' => 'A drug, or biological product that is used in a clinical trial but has not been approved by the FDA (the drug is either not available for a doctor to prescribe or, is available, but not approved by the FDA for the use being studied).',
'Industry' => 'Medical devices; Pharmaceutical',
'Part of Speech' => 'noun',
'Product Category' => 'Clinical trials',
'Creation User' => 'elighy',
'Creation Date' => '2012/10/13',
'Term' => 'investigational new drug',
'Source Lang' => '1180',
),
's_namespace_text' => 'EN',
's_namespace_text_full' => 'English (EN)',
's_title' => 'investigational_new_drug_₁',
)
investigational new drug
A drug, or biological product that is used in a clinical trial but has not been approved by the FDA (the drug is either not available for a doctor to prescribe or, is available, but not approved by the FDA for the use being studied).
Nouveau médicament expérimental
Un médicament ou produit biologique qui est utilisé dans un essai clinique, mais pas approuvé par la FDA (soit le médicament n'est pas disponible pour la prescription par un médecin, soit il est disponible, mais pas approuvé par la FDA pour l'utilisation en ...
Medical devices; Clinical trials
(object) array(
'id' => '6227765',
'url' => 'FR/inclusion_criteria',
'image' => '',
'title' => 'Critères d\'inclusion',
'tags' =>
array (
0 => 'Critères d\'inclusion',
1 => 'Medical devices',
2 => 'Pharmaceutical',
3 => 'Clinical trials',
4 => 'National Library of Medicine',
5 => '',
),
'term' => 'Critères d\'inclusion',
'source_id' => 4010895,
'type' => 'term',
'namespace' => 1244,
'nstext' => 'FR',
'industry' =>
array (
0 => 'Medical devices',
1 => 'Pharmaceutical',
),
'category' =>
array (
0 => 'Clinical trials',
),
'company' =>
array (
0 => 'National Library of Medicine',
),
'lastedit' => '20150722105913',
'part_of_speech' => 'noun',
'creation_user' => 'LinguaDiligence',
'special_term' => '',
'definition' => 'Les facteurs ou les raisons qui autorisent une personne à participer à une étude clinique.',
'usage_comment' => '',
'glossary' => '',
'width' => 0,
'height' => 0,
'_version_' => 1507393851745107969,
'nstext_full' => 'French (FR)',
's_attr' =>
(object) array(
'Company' => 'National Library of Medicine',
'Definition' => 'The factors or reasons that allow a person to participate in a clinical study.',
'Industry' => 'Medical devices; Pharmaceutical',
'Part of Speech' => 'noun',
'Product Category' => 'Clinical trials',
'Creation User' => 'elighy',
'Creation Date' => '2012/10/13',
'Term' => 'inclusion criteria',
'Source Lang' => '1180',
),
's_namespace_text' => 'EN',
's_namespace_text_full' => 'English (EN)',
's_title' => 'inclusion_criteria',
)
inclusion criteria
The factors or reasons that allow a person to participate in a clinical study.
Critères d'inclusion
Les facteurs ou les raisons qui autorisent une personne à participer à une étude clinique.
Medical devices; Clinical trials